Your browser doesn't support javascript.
loading
FACE-Q for Measuring Patient-reported Outcomes after Facial Skin Cancer Surgery: Cross-cultural Validation.
Ottenhof, Maarten J; Dobbs, Thomas D; Veldhuizen, Inge; Harrison, Conrad J; Marges, Michelle; Lee, Erica H; Hoogbergen, Maarten M; van der Hulst, René R W J; Pusic, Andrea L; Sidey-Gibbons, Chris J.
Afiliación
  • Ottenhof MJ; From Patient-Reported Outcomes, Value & Experience (PROVE) Center, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
  • Dobbs TD; Department of Surgery, Harvard Medical School, Boston, Mass.
  • Veldhuizen I; Department of Plastic and Reconstructive Surgery, Catharina Ziekenhuis, Eindhoven, the Netherlands.
  • Harrison CJ; Reconstructive Surgery and Regenerative Medicine Research Group, Institute of Life Sciences, Swansea University Medical School, Swansea, United Kingdom.
  • Marges M; Department of Plastic and Reconstructive Surgery, Catharina Ziekenhuis, Eindhoven, the Netherlands.
  • Lee EH; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
  • Hoogbergen MM; Department of Plastic and Reconstructive Surgery, Catharina Ziekenhuis, Eindhoven, the Netherlands.
  • van der Hulst RRWJ; Dermatology Division, Memorial Sloan Kettering Cancer Center, New York, N.Y.
  • Pusic AL; Department of Plastic and Reconstructive Surgery, Catharina Ziekenhuis, Eindhoven, the Netherlands.
  • Sidey-Gibbons CJ; Department of Plastic and Reconstructive Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.
Plast Reconstr Surg Glob Open ; 12(4): e5771, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38689944
ABSTRACT

Background:

Facial skin cancer and its surgical treatment can affect health-related quality of life. The FACE-Q Skin Cancer Module is a patient-reported outcome measure that measures different aspects of health-related quality of life and has recently been translated into Dutch. This study aimed to evaluate the performance of the translated version in a Dutch cohort using modern psychometric measurement theory (Rasch).

Methods:

Dutch participants with facial skin cancer were prospectively recruited and asked to complete the translated FACE-Q Skin Cancer Module. The following assumptions of the Rasch model were tested unidimensionality, local independence, and monotonicity. Response thresholds, fit statistics, internal consistency, floor and ceiling effects, and targeting were assessed for all scales and items within the scales. Responsiveness was tested for the "cancer worry" scale.

Results:

In total, 259 patients completed the preoperative questionnaire and were included in the analysis. All five scales assessed showed a good or sufficient fit to the Rasch model. Unidimensionality and monotonicity were present for all scales. Some items showed a local dependency. Most of the scales demonstrate ordered item thresholds and appropriate fit statistics.

Conclusions:

The FACE-Q Skin Cancer Module is a well-designed patient-reported outcome measure that shows psychometric validity for the translated version in a Dutch cohort, using classical and modern test theory.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Plast Reconstr Surg Glob Open Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Plast Reconstr Surg Glob Open Año: 2024 Tipo del documento: Article